[13] |
Livia C, Sugrue A, Witt T, et al. Elimination of Purkinje fibers by electroporation reduces ventricular fibrillation vulnerability[J]. J Am Heart Assoc, 2018, 7(15):e009070.
|
[14] |
Odegard KC, Vincent R, Baijal R, et al. SCAI/CCAS/SPA expert consensus statement for anesthesia and sedation practice: Recommendations for patients undergoing diagnostic and therapeutic procedures in the pediatric and congenital cardiac catheterization laboratory[J]. Catheter Cardiovasc Interv, 2016, 88(6):912-922.
|
[15] |
Prolič Kalinšek T, Šorli J, Jan M, et al. Conventional fluoroscopy-guided versus zero-fluoroscopy catheter ablation of supraventricular tachycardias[J]. BMC Cardiovasc Disord, 2022, 22(1):98.
|
[16] |
Koruth JS, Kuroki K, Kawamura I, et al. Focal pulsed field ablation for pulmonary vein isolation and linear atrial lesions: a preclinical assessment of safety and durability[J]. Circ Arrhythm Electrophysiol, 2020, 13(6):e008716.
|
[17] |
Reddy VY, Anic A, Koruth J, et al. Pulsed field ablation in patients with persistent atrial fibrillation[J]. J Am Coll Cardiol, 2020, 76(9):1068-1080.
|
[18] |
Ramirez FD, Reddy VY, Viswanathan R, et al. Emerging technologies for pulmonary vein isolation[J]. Circ Res, 2020, 127(1):170-183.
|
[19] |
Meckes D, Emami M, Fong I, et al. Pulsed-field ablation: Computational modeling of electric fields for lesion depth analysis[J]. Heart Rhythm O2, 2022, 3(4):433-440.
|
[1] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 室上性心动过速诊断及治疗中国专家共识(2021)[J]. 中华心律失常学杂志, 2022, 26(3):202-262.
|
[2] |
Hanninen M, Yeung-Lai-Wah N, Massel D, et al. Cryoablation versus RF ablation for AVNRT: a meta-analysis and systematic review[J]. J Cardiovasc Electrophysiol, 2013, 24(12):1354-1360.
|
[3] |
Verma A, Asivatham SJ, Deneke T, et al. Primer on pulsed electrical field ablation: understanding the benefits and limitations[J]. Circ Arrhythm Electrophysiol, 2021, 14(9):e010086.
|
[4] |
Verma A, Boersma L, Haines DE, et al. First-in-human experience and acute procedural outcomes using a novel pulsed field ablation system: the PULSED AF pilot trial[J]. Circ Arrhythm Electrophysiol, 2022, 15(1):e010168.
|
[5] |
Reddy VY, Neuzil P, Koruth JS, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation[J]. J Am Coll Cardiol, 2019, 74(3):315-326.
|
[6] |
Grimaldi M, Di Monaco A, Gomez T, et al. Time course of irreversible electroporation lesion development through short- and long-term follow-up in pulsed-field ablation-treated hearts[J]. Circ Arrhythm Electrophysiol, 2022, 15(7):e010661.
|
[7] |
Reddy VY, Anter E, Rackauskas G, et al. Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation: a first-in-human trial[J]. Circ Arrhythm Electrophysiol, 2020, 13(6):e008718.
|
[8] |
汤日波, 王祖禄, 殷跃辉,等. 国产三维心脏电生理标测系统用于持续性心房颤动导管消融的前瞻性、多中心、对照研究[J]. 中华心血管病杂志, 2016, 44(5):401-405.
|
[9] |
Akram MS, Ur Rehman J, Hall EA. Engineered proteins for bioelectrochemistry[J]. Annu Rev Anal Chem (Palo Alto Calif), 2014, 7:257-274.
|
[10] |
Reddy VY, Dukkipati SR, Neuzil P, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II[J]. JACC Clin Electrophysiol, 2021, 7(5):614-627.
|
[11] |
Ekanem E, Reddy VY, Schmidt B, et al. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)[J]. Europace, 2022, 24(8):1256-1266.
|
[12] |
van Zyl M, Ladejobi AO, Tri JA, et al. Reversible atrioventricular conduction impairment following bipolar nanosecond electroporation of the interventricular septum[J]. JACC Clin Electrophysiol, 2021, 7(2):255-257.
|